2013
DOI: 10.5152/akd.2013.147
|View full text |Cite
|
Sign up to set email alerts
|

Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine

Abstract: Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine ABSTRACTStudies indicate that 5-7% patients undergoing percutaneous coronary intervention (PCI) have an indication for anticoagulation therapy. Most commonly atrial fibrillation (AF) is the indication. These subjects require triple therapy with aspirin, clopidogrel, and an oral anticoagulant (OAC). Several questions, concerns and challenges exist regarding the duration,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…Integrated multi-omics studies are becoming increasingly important in the context of personalized medicine, where treatment decisions are based on patients’ omics, demographic, clinical and environmental data [7,8,9,10,11]. The recently released integrative personal omics profile (iPOP) study is a pioneering work in the field of personalized omics profiling.…”
Section: Introductionmentioning
confidence: 99%
“…Integrated multi-omics studies are becoming increasingly important in the context of personalized medicine, where treatment decisions are based on patients’ omics, demographic, clinical and environmental data [7,8,9,10,11]. The recently released integrative personal omics profile (iPOP) study is a pioneering work in the field of personalized omics profiling.…”
Section: Introductionmentioning
confidence: 99%